Cancer vaccines are an emerging personalised treatment for cancer. Using the same mRNA technology as COVID vaccines, they stimulate the immune system to destroy cancer cells.
Academic rigour, journalistic flair
Articles on Cancer treatment
Displaying 1 - 20 of 84 articles
Physical activity throughout cancer treatment is both safe and beneficial.
Kath O'Connor’s debut novel, Inheritance, follows two women – an IVF hopeful and her grandmother – who carry the BRCA1 gene and contract ovarian cancer. It’s very close to being memoir.
Some cancers are notoriously resistant to chemotherapy and not curable with surgery. Stopping tumors from adapting to the harsh microenvironments of the body could be a potential treatment avenue.
Many tumors have cancer stem cells that help them grow and evade treatments. Differentiation therapy forces these cells to mature, stopping growth with less toxicity than traditional treatments.
Both cancer and cancer treatment can impact someone’s ability to have biological children. It’s important to discuss fertility right after cancer diagnosis.
Click and bioorthogonal chemistry has enabled researchers to closely study how molecules work in their natural state in living organisms, with applications that span from cancer treatment to polymers.
Almost 4,000 Australians are diagnosed with head and neck cancer each year. Oral cancer is one type.
‘Point-of-care manufacture’ of advanced therapies is already being used in hospitals in the UK, Spain, Switzerland and the US.
Our ability to use mathematical modelling is accelerating breakthrough discoveries in health care and biotechnology.
Globally, most cancer patients die not because they don’t have access to newer drugs, but because they don’t have access to even basic treatments. Cancer groundshot aims to improve treatment access.
The COVID-19 mRNA vaccines put nanomedicine in the spotlight as a potential way to treat diseases like cancer and HIV. While the field isn’t there yet, better design could help fulfill its promise.
Drug repurposing can redeem failed treatments and squeeze out new uses from others. But many pharmaceutical companies are hesitant to retool existing drugs without a high return on investment.
We’ve found an unusual way of stabilising the cancer-suppressing protein p53.
New studies highlight the difficulties cancer patients have when discussing their illness with family and medical teams.
Artificial cells on tiny microfluidic chips can provide early insight into how new cancer drugs behave in cells, and why certain kinds of cancer are more resistant to chemotherapy treatment.
Promising results in mice show this rare form of cancer could be treated using the same drugs already used against one type of leukaemia.
Long non-coding RNAs were long thought to serve no purpose. Now, researchers think differently.
Tattoos might be the norm, but Surface Guided RadioTherapy for breast cancer is both more accurate, and doesn’t require a permanent mark.
Neutrons are useful in research and medicine. A proposed neutron production facility could help further Canadian research and provide a source of neutrons for medical purposes.
Top contributors
-
Associate Professor of the Sydney Pharmacy School, University of Sydney
-
Professorial Research Fellow. School of Psychology, Faculty of Health and Medical Sciences, University of Adelaide
-
NHMRC Senior Research Fellow, Centre for Cancer Biology, University of South Australia
-
University Distinguished Professor of Marketing, Mays Business School; Senior Fellow, Institute for Healthcare Improvement, Texas A&M University
-
Professor of Exercise Medicine, Edith Cowan University
-
Veronique Chachay is a Friend of The Conversation.
Research & Teaching Academic, The University of Queensland
-
Professor of Health Economics, Deputy Director of CHERE, University of Technology Sydney
-
Professor of Health Economics, University of Technology Sydney
-
Professor of Behavioural Ecology, UCL
-
Chancellor's Professor of Medicine, Liberal Arts, and Philanthropy, Indiana University
-
Lecturer in Robotics, University of Bristol
-
Associate Professor, Cornell University
-
Professor of Experimental Cancer Therapeutics, Institute of Cancer Research, London
-
Lecturer in Speech Pathology, The University of Queensland
-
Dean, Graduate Research, University of Canberra
